AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36055582 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention at 12 months (follow-up)
Number of subjects: 382
Study 36055582 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention differences by gender or race/ethnicity
Number of subjects: 382
Study 36055582 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention differences by recruitment method
Number of subjects: 382
Study 34185442 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal status
Number of subjects: 303
Study 34185442 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of teeth
Number of subjects: 303
Study 34185442 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic status (SES)
Number of subjects: 303
Study 36348460 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage 1 outline applications
Number of subjects: 95
Study 36348460 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage 2 full applications
Number of subjects: 95
Study 33203399 — intervention group
Group type: EXPERIMENTAL
Intervention: docetaxel-sunitinib
Number of subjects: 68
Study 33203399 — intervention group
Group type: COMPARATOR
Intervention: docetaxel
Number of subjects: 68
Study 36181096 — intervention group
Group type: EXPERIMENTAL
Intervention: Teach-back method
Number of subjects: 100
Study 36181096 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 100
Study 32885909 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal lifestyle intervention
Number of subjects: 277
Study 32885909 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive parenting intervention
Number of subjects: 277
Study 32885909 — intervention group
Group type: COMPARATOR
Intervention: Attention control (home safety)
Number of subjects: 277
Study 35715661 — intervention group
Group type: EXPERIMENTAL
Intervention: Oversight arm
Number of subjects: 140
Study 35715661 — intervention group
Group type: COMPARATOR
Intervention: Non-oversight arm
Number of subjects: 140
Study 34509801 — intervention group
Group type: EXPERIMENTAL
Intervention: safinamide 50 mg
Number of subjects: 0
Study 34509801 — intervention group
Group type: EXPERIMENTAL
Intervention: safinamide 100 mg
Number of subjects: 0
Study 34509801 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 34509801 — intervention group
Group type: EXPERIMENTAL
Intervention: safinamide 50 mg and 100 mg
Number of subjects: 0
Study 32132009 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic diabetes self-management intervention (Bronx A1C)
Number of subjects: 816
Study 32132009 — intervention group
Group type: COMPARATOR
Intervention: Print-only (PrO) control arm
Number of subjects: 816
Study 35973188 — intervention group
Group type: COMPARATOR
Intervention: Freshwater fish-based and red meat-based diet alternately (F/M group)
Number of subjects: 34
Study 33683991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivosidenib
Number of subjects: 0
Study 33683991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32065514 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-05221304 (1-240 mg single doses or 2-200 mg daily repeated doses for 14 days)
Number of subjects: 96
Study 32065514 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-05221304 (repeated doses)
Number of subjects: 96
Study 32065514 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-05221304 (doses yielding ≥90% DNL inhibition)
Number of subjects: 96
Study 32065514 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-05221304 (steady-state pharmacokinetics)
Number of subjects: 96
Study 35333207 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid microinjection
Number of subjects: 29
Study 35333207 — intervention group
Group type: COMPARATOR
Intervention: Fractional CO2 laser
Number of subjects: 29
Study 32286132 — intervention group
Group type: EXPERIMENTAL
Intervention: HMD‐VR
Number of subjects: 40
Study 32286132 — intervention group
Group type: COMPARATOR
Intervention: Traditional computer monitor
Number of subjects: 40
Study 33623830 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-adhesion gel
Number of subjects: 444
Study 33623830 — intervention group
Group type: COMPARATOR
Intervention: No gel (control group)
Number of subjects: 444
Study 32513069 — intervention group
Group type: EXPERIMENTAL
Intervention: Naringin 450 mg every 24 hours for 90 days
Number of subjects: 28
Study 32513069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 33410265 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sofpironium bromide (BBI-4000) gel
Number of subjects: 281
Study 33410265 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 281
Study 32677999 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HST) with post-test phone counseling and referral (eTest condition)
Number of subjects: 900
Study 32677999 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HST) without active follow-up (standard condition)
Number of subjects: 900
Study 32677999 — intervention group
Group type: COMPARATOR
Intervention: Reminders to get tested for HIV at a local clinic (control)
Number of subjects: 900
Study 35361724 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxadustat (oral, three times weekly)
Number of subjects: 2133
Study 35361724 — intervention group
Group type: COMPARATOR
Intervention: Epoetin alfa (parenteral, per local clinic practice)
Number of subjects: 2133
Study 35361724 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 2133
Study 35361724 — intervention group
Group type: COMPARATOR
Intervention: Epoetin alfa
Number of subjects: 2133
Study 34622680 — intervention group
Group type: COMPARATOR
Intervention: Low-volume centers (n=537)
Number of subjects: 1032
Study 34622680 — intervention group
Group type: COMPARATOR
Intervention: Intermediate-volume centers (n=240)
Number of subjects: 1032
Study 34622680 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume centers (n=255)
Number of subjects: 1032
Study 34622680 — intervention group
Group type: EXPERIMENTAL
Intervention: All volume categories
Number of subjects: 1032
Study 33608398 — intervention group
Group type: EXPERIMENTAL
Intervention: Early continuous renal replacement therapy (CRRT) initiated immediately after randomisation
Number of subjects: 460
Study 33608398 — intervention group
Group type: COMPARATOR
Intervention: Delayed continuous renal replacement therapy (CRRT) initiated based on specific criteria (stage 3 KDIGO, severe hyperkalaemia, pulmonary oedema, blood urea nitrogen > 112 mg/dL)
Number of subjects: 460
Study 33608398 — intervention group
Group type: EXPERIMENTAL
Intervention: Early CRRT
Number of subjects: 460
Study 33608398 — intervention group
Group type: COMPARATOR
Intervention: Delayed CRRT
Number of subjects: 460
Study 32844606 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapulmonary percussive ventilation (IPV) for 20 minutes in upright position, 2 hours postprandial.
Number of subjects: 100
Study 32844606 — intervention group
Group type: COMPARATOR
Intervention: Control group received no intervention, placed in the same position for 20 minutes, 2 hours postprandial.
Number of subjects: 100
Study 35902953 — intervention group
Group type: EXPERIMENTAL
Intervention: HMD‐VRC group
Number of subjects: 30
Study 35902953 — intervention group
Group type: COMPARATOR
Intervention: RP group
Number of subjects: 30
Study 33377903 — intervention group
Group type: EXPERIMENTAL
Intervention: hrHPV testing
Number of subjects: 60732
Study 33377903 — intervention group
Group type: COMPARATOR
Intervention: Cytology triage for hrHPV-positive rural women
Number of subjects: 60732
Study 33377903 — intervention group
Group type: COMPARATOR
Intervention: Genotyping for hrHPV with cytology triage
Number of subjects: 60732
Study 32035420 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 592
Study 32035420 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 592
Study 36126290 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT)
Number of subjects: 32
Study 36126290 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (zero-intensity laser)
Number of subjects: 32
Study 35757424 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity Interval Resistance Training (LIIRT)
Number of subjects: 44
Study 35757424 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Interval Resistance Training (MIIRT)
Number of subjects: 44
Study 35757424 — intervention group
Group type: COMPARATOR
Intervention: High-Intensity Interval Resistance Training (HIIRT)
Number of subjects: 44
Study 35757424 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 44
Study 32192482 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized 3D-printed navigation templates
Number of subjects: 35
Study 32192482 — intervention group
Group type: COMPARATOR
Intervention: Traditional surgery
Number of subjects: 35
Study 35341915 — intervention group
Group type: EXPERIMENTAL
Intervention: Complement and coagulation proteins
Number of subjects: 158
Study 35341915 — intervention group
Group type: COMPARATOR
Intervention: Cytokines, proteomic or fatty acid data
Number of subjects: 158
Study 32659116 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT+RT (cycling 4 bouts of 4-min at 90% of HRmax followed by 3 sets of 12 repetitions of 3 lower limb free-weight exercises)
Number of subjects: 87
Study 32659116 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT+HIIT (cycling 5 bouts of 4 min at 90% of HRmax)
Number of subjects: 87
Study 32659116 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 87
Study 35247245 — intervention group
Group type: EXPERIMENTAL
Intervention: Small incision open reduction and cannulated screw internal fixation
Number of subjects: 72
Study 35247245 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic high strength non-absorbable suture
Number of subjects: 72
Study 32888230 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (n = 407)
Number of subjects: 1051
Study 32888230 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination nicotine replacement therapy (C‐NRT) (n = 421)
Number of subjects: 1051
Study 32888230 — intervention group
Group type: COMPARATOR
Intervention: Nicotine patch monotherapy (control) (n = 230)
Number of subjects: 1051
Study 35945001 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial Fibrillation (AF)
Number of subjects: 2844
Study 33938053 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedrest (BR)
Number of subjects: 15
Study 33938053 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 15
Study 35275196 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD4017 (400 mg oral, twice daily for 90 days)
Number of subjects: 55
Study 35275196 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matched placebo for 90 days)
Number of subjects: 55
Study 35275196 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD4017
Number of subjects: 55
Study 35644168 — intervention group
Group type: EXPERIMENTAL
Intervention: dNS1-RBD vaccine (intranasal spray)
Number of subjects: 1084
Study 34030885 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant uracil‐tegafur and leucovorin
Number of subjects: 180
Study 34030885 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 180
Study 34030885 — intervention group
Group type: EXPERIMENTAL
Intervention: Curative repeated resection
Number of subjects: 180
Study 33104433 — intervention group
Group type: COMPARATOR
Intervention: Standard care (bordered polyurethane dressing plus nonsterile tape over the extension tubing)
Number of subjects: 105
Study 33104433 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus two sterile tape strips over the PIVC hub
Number of subjects: 105
Study 33104433 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus two sterile tape strips over the PIVC hub plus a tubular bandage
Number of subjects: 105
Study 36027994 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning Label (WL)
Number of subjects: 1951
Study 36027994 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline Dietary Amounts (GDA)
Number of subjects: 1951
Study 36027994 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Traffic Light (MTL)
Number of subjects: 1951
Study 36027994 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no label)
Number of subjects: 1951
Study 32508218 — intervention group
Group type: EXPERIMENTAL
Intervention: Algebraic equation solving intervention (Mystery Math), 30 min per session, 3 sessions per week for 5 weeks (15 sessions)
Number of subjects: 48
Study 32508218 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 48
Study 32002583 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg propranolol orally every 12 hours up to 10 days or until discharge (BB+)
Number of subjects: 219
Study 32002583 — intervention group
Group type: COMPARATOR
Intervention: No propranolol (BB-)
Number of subjects: 219
Study 34474598 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized executive function training program under the guidance of a coach
Number of subjects: 70
Study 34474598 — intervention group
Group type: COMPARATOR
Intervention: Waiting group (control)
Number of subjects: 70
Study 34459396 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-value care (LvC)
Number of subjects: 516
Study 34459396 — intervention group
Group type: EXPERIMENTAL
Intervention: High-value care (HvC)
Number of subjects: 516
Study 36339271 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimavanserin
Number of subjects: 298
Study 36339271 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study 35226566 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic interval training (AIT)
Number of subjects: 31
Study 35226566 — intervention group
Group type: COMPARATOR
Intervention: Moderate continuous training (MCT)
Number of subjects: 31
Study 32476080 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 2075
Study 33966952 — intervention group
Group type: EXPERIMENTAL
Intervention: DARTNA (Drum-Assisted Recovery Therapy for Native Americans)
Number of subjects: 63
Study 33966952 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus (control group)
Number of subjects: 63
Study 32869931 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF, 0.1%) cream with linoleic acid-ceramide (LA-Cer) moisturizer
Number of subjects: 178
Study 32869931 — intervention group
Group type: COMPARATOR
Intervention: Mometasone furoate (MF, 0.1%) cream
Number of subjects: 178
Study 36367488 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training
Number of subjects: 79
Study 36367488 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load resistance training and aerobic training
Number of subjects: 79
Study 36367488 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load resistance training and aerobic training
Number of subjects: 79
Study 36367488 — intervention group
Group type: EXPERIMENTAL
Intervention: Very sedentary patients
Number of subjects: 79
Study 36367488 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary patients
Number of subjects: 79
Study 33559168 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity extracorporeal shock wave therapy (Li-ESWT) plus pelvic floor muscle training
Number of subjects: 42
Study 33559168 — intervention group
Group type: COMPARATOR
Intervention: Pelvic floor muscle exercise and sham therapy by shock wave
Number of subjects: 42
Study 32236752 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction with post-exercise carbohydrate (CRC)
Number of subjects: 3
Study 32236752 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction with post-exercise protein (CRP)
Number of subjects: 3
Study 32236752 — intervention group
Group type: COMPARATOR
Intervention: Energy balance control (CON)
Number of subjects: 3
Study 32236752 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction (CRC)
Number of subjects: 3
Study 32236752 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction (CRP)
Number of subjects: 3
Study 35858717 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block alone (ACB)
Number of subjects: 0
Study 35858717 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block with low-concentration sciatic nerve block (ACB + LC SNB)
Number of subjects: 0
Study 35858717 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block with high-concentration sciatic nerve block (ACB + HC SNB)
Number of subjects: 0
Study 34830677 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual reminiscence therapy (RT) sessions, twice weekly for 13 weeks
Number of subjects: 0
Study 34830677 — intervention group
Group type: COMPARATOR
Intervention: Regular activities administered as part of their program (Control)
Number of subjects: 0
Study 35996179 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 or 6 mg NRT chewing gum for 8 weeks
Number of subjects: 350000000
Study 35996179 — intervention group
Group type: EXPERIMENTAL
Intervention: BISCA: face-to-face behavioural support for ST cessation
Number of subjects: 350000000
Study 35996179 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of interventions A and B
Number of subjects: 350000000
Study 35996179 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Very Brief Advice - VBA)
Number of subjects: 350000000
Study 32671561 — intervention group
Group type: EXPERIMENTAL
Intervention: Field margin vegetation assessment using remote sensing and geo-informatics techniques
Number of subjects: 355
Study 32671561 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological knowledge of local farmers regarding FMV
Number of subjects: 355
Study 32671561 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of species dominance in rural vs urban zones
Number of subjects: 355
Study 36279410 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex
Number of subjects: 58
Study 36279410 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine
Number of subjects: 58
Study 33355478 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive mangosteen pericarp (1,000 mg/day)
Number of subjects: 148
Study 33355478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 32414832 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training programme consisting of motor control exercise and segmental exercises; specific dosage and duration not provided.
Number of subjects: 0
Study 35396879 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated resolution therapy (ART)
Number of subjects: 29
Study 35396879 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 29
Study 33653932 — intervention group
Group type: EXPERIMENTAL
Intervention: SRI app
Number of subjects: 60
Study 33653932 — intervention group
Group type: COMPARATOR
Intervention: Classic paper SRI
Number of subjects: 60
Study 32567948 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual distraction using video eyeglasses
Number of subjects: 48
Study 32567948 — intervention group
Group type: COMPARATOR
Intervention: Conventional behaviour management techniques
Number of subjects: 48
Study 36325897 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab 75 mg or 150 mg every 2 weeks as an adjunct to background treatment
Number of subjects: 18
Study 32071052 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitazoxanide (NTZ) 1 g orally twice daily for 14 days
Number of subjects: 30
Study 32071052 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 30
Study 33848255 — intervention group
Group type: EXPERIMENTAL
Intervention: Spelling Errors and Shouting Capitalization
Number of subjects: 0
Study 33848255 — intervention group
Group type: COMPARATOR
Intervention: Control (no spelling errors or shouting capitalization)
Number of subjects: 0
Study 32336479 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral paracetamol
Number of subjects: 161
Study 32336479 — intervention group
Group type: COMPARATOR
Intervention: Oral ibuprofen
Number of subjects: 161
Study 35085510 — intervention group
Group type: EXPERIMENTAL
Intervention: Baloxavir plus NAIs
Number of subjects: 366
Study 35085510 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus NAIs (Control)
Number of subjects: 366
Study 33909726 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilient stud (Locator)
Number of subjects: 30
Study 33909726 — intervention group
Group type: COMPARATOR
Intervention: Stress‐free implant bar (SFI‐Bar)
Number of subjects: 30
Study 33909726 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 35484309 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine pouch (NP)
Number of subjects: 34
Study 35484309 — intervention group
Group type: COMPARATOR
Intervention: Lozenge
Number of subjects: 34
Study 35484309 — intervention group
Group type: COMPARATOR
Intervention: Gum
Number of subjects: 34
Study 34529962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV (5×10^10 viral particles) followed by MVA-BN-Filo (1×10^8 infectious units) on day 57
Number of subjects: 576
Study 34529962 — intervention group
Group type: COMPARATOR
Intervention: MenACWY (first dose) followed by placebo (second dose) on day 57
Number of subjects: 576
Study 34529962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen
Number of subjects: 576
Study 35640923 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epicardial and endocardial approach
Number of subjects: 100
Study 35640923 — intervention group
Group type: COMPARATOR
Intervention: Conventional endocardial approach
Number of subjects: 100
Study 32621543 — intervention group
Group type: EXPERIMENTAL
Intervention: MHAA4549A 3600 mg
Number of subjects: 158
Study 32621543 — intervention group
Group type: EXPERIMENTAL
Intervention: MHAA4549A 8400 mg
Number of subjects: 158
Study 32621543 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study 616766147 — intervention group
Group type: EXPERIMENTAL
Intervention: AMF+NFB combinations
Number of subjects: 6
Study 616766147 — intervention group
Group type: COMPARATOR
Intervention: Control treatments (no AMF or NFB)
Number of subjects: 6
Study 616766147 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-inoculation of AMF and NFB
Number of subjects: 6
Study 36283845 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous analgesic system (SAS)
Number of subjects: 36
Study 36283845 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 36